4.7 Article

ICOS ligand costimulation is required for T-cell encephalitogenicity

Journal

CLINICAL IMMUNOLOGY
Volume 100, Issue 3, Pages 277-288

Publisher

ACADEMIC PRESS INC
DOI: 10.1006/clim.2001.5074

Keywords

EAE/MS; costimulatory molecules; T-lymphocytes; immunotherapy

Categories

Funding

  1. NIAID NIH HHS [R29-AI43296] Funding Source: Medline

Ask authors/readers for more resources

The interaction of ICOS with its ligand on APC provides a costimulatory signal to previously activated T-cells. In these studies, we blocked the ICOS:ICOS ligand interaction with ICOS-Ig during the in vitro activation of AMP-reactive transgenic CD4(+) T-cells. The presence of ICOS-Ig in these cultures inhibited the ability of the transgenic T-cells to transfer EAE, although they entered the brains of the recipient mice. ICOS-Ig increased apoptosis in the transgenic T-cells, especially in the memory population. This enhanced apoptosis was accompanied by an increase in the BAX/BCL-2 mRNA ratio. ICOS-Ig did not prevent IL2 production, demonstrating that IL-2 production is ICOS ligand independent. IFN-gamma and IL-10 production by the transgenic T-cells, however, was suppressed. Finally, ICOS-Ig injection into mice after the first signs of EAE ameliorated clinical disease. Therefore, ICOS-Ig provides a signal distinct from CD28 costimulation that is required for the activation and viability of encephalitogenic T-cells. (C) 2001 Academic Press.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available